Posted by jrbecker on July 28, 2004, at 20:42:50
Neurocrine, Inc. in alliance with GSK will push forward with a Phase I trial of a CRF1 antagonist compound by year-end 2004.
http://biz.yahoo.com/prnews/040728/law105_1.html
Neurogen, Inc., in collaboration with Aventis,
has stated that it will go ahead with a compound of its own in 2005.Other companies developing these compounds include Janssen (J&J), Pfizer, and Bristol-Myers Squibb.
poster:jrbecker
thread:371835
URL: http://www.dr-bob.org/babble/20040724/msgs/371835.html